Patent Term Extension Application for LAMZEDE (velmanase alfa-tycv), Patent No. 10,159,718
🏛 Food and Drug Administration (FDA)FDA-2023-E-3270
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.